NEW YORK, NY – April 23, 2024 – Edgemont Partners (“Edgemont”), a premier healthcare-dedicated investment bank and leading M&A and capital raising advisor, is pleased to announce that Dan Nicholson has joined the firm as a Managing Director to lead and expand its Medical Technology coverage efforts.

Mr. Nicholson brings a deep knowledge of corporate finance and proven advisory expertise from over 15 years of experience advising both public and private companies in a variety of merger and acquisition, capital raising and strategic transactions. He has executed over 65 healthcare transactions representing more than $27.5 billion in aggregate value.

Mr. Nicholson joins Edgemont from Jefferies, where he served as a Senior Vice President advising companies in the Medical Technology and Dental Products sectors. Prior to Jefferies, Mr. Nicholson held roles at C.R. Bard and KPMG. Mr. Nicholson earned a Bachelor of Science degree in accounting and a Master of Business Administration degree in Finance from Saint Peter’s College.

Mr. Nicholson will be based in Edgemont’s New York office, reporting to Co-Founders David Blume and Jeff Swearingen.

About Edgemont Partners
Founded in 2001, Edgemont ranks among the most active and best-performing independent healthcare M&A and financial advisors in the U.S. We focus solely on providing expert strategic advice and transaction execution to healthcare and life sciences companies, bringing a steadfast commitment to our clients, driven always to prioritize their best interests. Edgemont’s principals have executed 200+ transactions with an aggregate value of $90 billion+.

Investment banking services are provided by Edgemont Capital Partners, LP, a registered broker-dealer and member of FINRA and SIPC.